Cancer Clinical Trial - NCT03355066

The purpose of this research study is to learn more about the safety and activity of a new experimental drug, SM08502 (the "study drug"). An experimental drug is a drug that has not been approved by the US Food and Drug Administration (FDA). In particular, this study will try to find out the highest dose of the study drug that can be safely taken by subjects with advanced solid tumors (or cancer).

Drug

SMO8502

Age Range

18 years or older

Phase

Phase 1

Condition

Solid Tumors

Keywords

Samumed | solid tumor